ResultsIQ

ResultsIQ › Latest results › Amanta Healthcare Limited

Amanta Healthcare Limited Q4 FY26 earnings call summary

NSE: AMANTA · BSE: 544502

Earnings call of 19 May 2026, summarised by AI from the filing.

SteriPort capacity expansion from 6.6 crore to 12 crore bottles per year.

Key takeaways

  1. Growth driver SteriPort capacity expansion from 6.6 crore to 12 crore bottles per year.
  2. Risk Polymer prices up 60-70%, but price hikes taken to remain neutral.

Original filing on BSE

Amanta Healthcare Limited Q1 FY27 results

As filed: Revenue ₹68.8 cr (+6% year on year), EBITDA ₹14.5 cr (−3% year on year), PAT ₹3.3 cr (−17% year on year), EBITDA margin 21.1% (−194 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹77.0 cr, EBITDA ₹15.0 cr, PAT ₹5.5 cr, EBITDA margin 19.4%. Not scored. No result for the same quarter last year. Share price after the results: +18.4% in 30 days (Nifty 500: +3.3%).
  • Q3 FY26: Revenue ₹74.5 cr, EBITDA ₹15.4 cr, PAT ₹4.6 cr, EBITDA margin 20.6%. Not scored. No result for the same quarter last year. Share price after the results: −7.2% in 30 days (Nifty 500: −7.5%).
  • Q2 FY26: Revenue ₹71.0 cr, EBITDA ₹15.0 cr, PAT ₹1.0 cr, EBITDA margin 21.1%. Not scored. No result for the same quarter last year. Share price after the results: −15.9% in 30 days (Nifty 500: −0.6%).
  • Q1 FY26: Revenue ₹65.0 cr, EBITDA ₹15.0 cr, PAT ₹4.0 cr, EBITDA margin 23.1%. Not scored. No result for the same quarter last year. Share price after the results: −9.5% in 28 days (Nifty 500: +4.3%).

Past price moves after results do not indicate future moves. Not a recommendation.

Amanta Healthcare Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.